Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Plague - Overview
Plague - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Plague - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Plague - Companies Involved in Therapeutics Development
Aradigm Corp (Ictive)
Enesi Pharma Ltd
FasCure Therapeutics LLC
Greffex Inc
iBio Inc
Norwell Inc
Opal Biosciences Ltd
Prokarium Ltd
Plague - Drug Profiles
(anthrax + plague) (multivalent) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
anthrax + plague vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
BDM-I - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ciprofloxacin - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
GrePla - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ISAS-02 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
plague (trivalent) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
plague vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
plague vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
plague vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
plague vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
plague vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
plague vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
pneumonic plaque vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules for Plague - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
VypVaxDuo - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Plague - Dormant Projects
Plague - Discontinued Products
Plague - Product Development Milestones
Featured News & Press Releases
Oct 31, 2019: Clinical development of a new vaccine for rapid response against Plague: GMP
Mar 08, 2017: DynPorts clinical stage recombint Yersinia pestis rF1V plague vaccine to benefit from FDA Orphan Drug Desigtion
Oct 31, 2016: Rapid, simple manufacture and clinical evaluation of an oral plague vaccine
Sep 30, 2016: Self-administered vaccines directed against Plague and MERS
Feb 14, 2013: BioDiem Extends Cooperative Agreement With USAMRIID
Jun 05, 2008: Computer Sciences Corporation’s DynPort Vaccine Company To Continue Plague Vaccine Development
Nov 18, 2005: Computer Sciences Corporation’s DynPort Vaccine Company Reaches Milestone In Plague Vaccine Clinical Trial
May 17, 2005: Wake Forest Scientists Find New Combition Vaccine Effective Against Plague
Jan 10, 2005: Computer Sciences Corporation’s DynPort Vaccine Company Enters Clinical Trial For Plague Vaccine Candidate
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures


Number of Products under Development for Plague, 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Universities/Institutes, 2021
Number of Products by Targets, 2021
Number of Products by Stage and Targets, 2021
Number of Products by Mechanism of Actions, 2021
Number of Products by Stage and Mechanism of Actions, 2021
Number of Products by Routes of Administration, 2021
Number of Products by Stage and Routes of Administration, 2021
Number of Products by Molecule Types, 2021
Number of Products by Stage and Molecule Types, 2021


List of Tables


Number of Products under Development for Plague, 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Universities/Institutes, 2021
Products under Development by Companies, 2021
Products under Development by Universities/Institutes, 2021
Number of Products by Stage and Target, 2021
Number of Products by Stage and Mechanism of Action, 2021
Number of Products by Stage and Route of Administration, 2021
Number of Products by Stage and Molecule Type, 2021
Plague - Pipeline by Aradigm Corp (Inactive), 2021
Plague - Pipeline by Enesi Pharma Ltd, 2021
Plague - Pipeline by FasCure Therapeutics LLC, 2021
Plague - Pipeline by Greffex Inc, 2021
Plague - Pipeline by iBio Inc, 2021
Plague - Pipeline by Norwell Inc, 2021
Plague - Pipeline by Opal Biosciences Ltd, 2021
Plague - Pipeline by Prokarium Ltd, 2021
Plague - Dormant Projects, 2021
Plague - Dormant Projects, 2021 (Contd..1)
Plague - Discontinued Products, 2021